ArticleJournal of advanced research2026
Disruption of PRC1 components RING1A and RING1B promotes angiogenesis via relieving BMP4 repression.
Article in Journal of advanced research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- DOT1L Drives Endothelial-to-Mesenchymal Transition and Fibrotic Vascular Remodeling via H3K79 Methylation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAngiogenesis is crucial for tissue homeostasis and vascular regeneration following ischemia or injury. Epigenetic regulation has emerged as a key determinant of angiogenic gene expression. The Polycomb repressive complex 1 (PRC1) is a major epigenetic regulator that mediates gene silencing through monoubiquitylation of histone H2A at lysine 119 (H2AK119ub), a process primarily catalyzed by its core components RING1A and RING1B. However, the role of RING1A and RING1B in angiogenesis remains unclear.
objectivesIn this study, we aimed to investigate the function and underlying mechanism of RING1A and RING1B in regulating endothelial cell functions and angiogenesis.
methodsWe performed loss-of-function experiments using siRNAs targeting RING1A and RING1B in vitro and in vivo. Endothelial function was evaluated by tube formation, acetylated low-density lipoprotein (ac-LDL) uptake, nitric oxide production, proliferation, and migration. To identify downstream targets, we integrated RNA sequencing data from RING1A or RING1B knockdown endothelial cells with Cleavage Under Targets and Tagmentation profiling of RING1A, RING1B, and H2AK119ub. In vivo angiogenesis was examined using a Matrigel plug model and a corneal alkali-burn injury model in mice.
resultsKnockdown of RING1A and RING1B significantly promoted tube formation, ac-LDL uptake, and nitric oxide production. Notably, only RING1A knockdown impaired endothelial proliferation and migration. Both RING1A and RING1B knockdown drastically promoted angiogenesis in vivo. Integrative analysis identified BMP4 as a direct transcriptional target of PRC1-mediated repression during angiogenesis.
conclusionOur findings indicate that RING1A and RING1B play a repressive role in angiogenesis by epigenetically silencing BMP4 gene expression through H2AK119ub. Targeting PRC1-mediated repression may represent a novel therapeutic approach to promote angiogenesis in ischemic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.